Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Website URL
Similar Companies1000
Cessation Therapeutics
Cessation Therapeutics is a company that develops immunotherapy-based biotech innovation to provide therapeutics for addiction-free living.
Sector
Subsector
Keywords
Location
total rounds
Unicycive Therapeutics
Unicycive Therapeutics is a biotechnology company that develops treatments for kidney diseases with significant unmet medical needs.
Sector
Subsector
Location
total rounds
total raised
Nextera AS
Nextera AS offers a versatile and innovative platform for developing novel therapeutic drugs.
Sector
Subsector
Keywords
Location
total rounds
NFlection Therapeutics
NFlection is a biopharmaceutical company that develops novel therapies to address the needs of patients with rare disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 19.05.2019. Their latest round Seed
SOSV
SOSV is a global venture capital firm that supports early-stage startups.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors3
Number of lead investors
Number of investors
Velocity
Velocity is a corporate investor based in Waterloo, Canada that focuses on funding early-stage tech startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
SOSV
SOSV is a global venture capital firm that supports early-stage startups.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Arvind Gupta
Arvind Gupta co-leads Mayfield’s Engineering Biology practice. He was the first investor in breakout bio companies such as Geltor, Synthex, Prime Roots, NotCo, Prellis, New Culture, DNA Lite and Memphis Meats. As Founder of IndieBio, Arvind redefined the pace and possibilities of early stage biotech, investing in over 136 companies in five years, defining human and planetary health, and growing the IndieBio portfolio into billions of dollars in value. Under his leadership, IndieBio expanded to New York and grew to fifteen investment professionals with a world class adjunct partner board. He is now Venture Advisor at IndieBio. Arvind is the author of Decoding the World: A Roadmap for the Questioner, published by Twelve Books, a division of the Hachette Publishing Group. He was honored with the F50 Global Award for Impact in HealthTech Innovation. He is a frequent speaker at TechCrunch Disrupt, Slush, TedX and Future FoodTech. His work has been profiled in global media outlets such as Bloomberg News, Forbes, The Guardian UK, Neo.life, Nikkei News, Rotman, The Times of India, and CGTN in China. Arvind has been a guest lecturer at UCSF, MIT and Harvard and is a judge at the annual BIO conference startup stadium. Prior to founding IndieBio, Arvind was Design Director at IDEO in Shanghai where he earned numerous international design awards and presented his work at the San Francisco Museum of Modern Art. Arvind received his B.S. in Genetic Engineering from UCSB. He holds 8 patents. Arvind is married to an Icelander and has two daughters.
current job
organization founded
IndieBio
IndieBio is a biotechnology and life science startup accelerator that focuses on solving global problems using biology.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists